CD8A and neoplasm: Indeed, knockdown of HMGCR significantly increases the overall number of tumor-infiltrating CD8+ T cells (TILs) or tumor-reactive CD8+ TILs in P3 tumors treated with anti-PD-1 Abs, which is accompanied by increased ferroptosis.